Avalon Correctional Services Inc
Change company Symbol lookup
Select an option...
CITY Avalon Correctional Services Inc
TEVJF Teva Pharmaceutical Industries Ltd
UMBF UMB Financial Corp
OXM Oxford Industries Inc
ICON Iconix Brand Group Inc
BAC Bank of America Corp
ON ON Semiconductor Corp
EQNR Equinor ASA
HNORF Harvey Norman Holdings Ltd
ASGN ASGN Inc
Go

Company profile

Avalon Correctional Services, Inc. (Avalon) is a developer and operator of halfway houses in Oklahoma, Texas and Wyoming. The Company's halfway houses and local, community partners provide men and women with the skills, guidance, knowledge, and resources necessary to make the transition from incarceration to free society. The Company offers residential reentry facilities, drug courts and treatment centers, among others. It provides housing, food, counseling, training, and other services to those in its care. The Company's facilities include Austin Residential Reentry Center, Austin Transitional Center, Carver Transitional Center, Carver Center Veteran Residential Program, Cheyenne Transitional Center, Corpus Christi Transitional Center, Dallas Transitional Center, El Paso Multi-Use Facility, El Paso Transitional Center, Fort Worth Transitional Center, Turley Residential Center and Tulsa Transitional Center. The Company is a subsidiary of CCA.

Closing Price
--
Day's Change
--
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
--

Aurora Cannabis reiterated as overweight as Cantor Fitzgerald welcomes Reliva deal

7:20 am ET May 21, 2020 (MarketWatch)
Print

Cantor Fitzgerald reiterated its overweight rating on shares of Aurora Cannabis Inc. (ACB.T) on Thursday and raised its stock price target to C$27 ($19) from C$22, after the company announced a long-awaited push into the U.S. cannabis market, via the $40 million all-stock purchase of a cannabidiol maker called Reliva (http://www.marketwatch.com/story/aurora-cannabis-makes-its-long-awaited-push-into-the-us-with-reliva-cbd-acquisition-2020-05-20). "ACB proved last Thursday (5/14) that it is making great strides with its reset (divestitures, cost cuts, cash flow improvement), and played down the risk of further dilution," analyst Pablo Zuanic wrote in a note to clients, referring to the company's better-than-expected quarterly earnings. The analyst views the Reliva deal as one likely to boost EBITDA and said it's reasonably priced compared with other deals, "as long as it does not distract from progress in the Canadian and European cannabis markets. Certainly, the consumer CBD industry faces temporary challenges in the US, but the industry has long-term upside, valuations have pulled back, and we think Reliva has a unique channel and price positioning that allowed it to perform quite well pre-COVID," Zuanic wrote. Aurora's stock price rally in the last three days -- it has gained about 230% in a move that comes after a long slide -- is "understandable," he said, adding that the South Korean and Swiss sovereign funds that have taken stakes would probably agree. "But in a growth industry, we also judge companies based on the platforms they are building for future growth," said the note. "We also sense the deal has other intangibles: it strengthens the ACB senior management bench, brings global CPG connections that may be useful, and should help reinvigorate ACB's alliance with the UFC," said the note. Aurora shares were up 29% premarket, but are still down 51% in the year to date, while the Cannabis ETF (THCX) has fallen 24% and the S&P 500 has fallen 8%.

-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

May 21, 2020 07:20 ET (11:20 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.